Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
Shizhan Ma,1,2 Wenxiu Sun,3 Ling Gao,1,4,5 Shudong Liu61Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, People’s Republic of China; 2Department of Endocrinology and Metabolism, Shandong Provincial Hospi...
Guardado en:
Autores principales: | Ma S, Sun W, Gao L, Liu S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/890045ebd0fe4acaa92cd746c3274381 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review
por: Sun F, et al.
Publicado: (2021) -
Circulating microparticle subpopulation in metabolic syndrome: relation to oxidative stress and coagulation markers
por: Zahran AM, et al.
Publicado: (2019) -
Assessment of Cardiovascular Risk Factors in Patients with Type 2 Diabetes in Upper Egypt Villages
por: Hussein A, et al.
Publicado: (2020) -
Effect of NPC1L1 and HMGCR Genetic Variants With Premature Triple-Vessel Coronary Disease
por: Xueyan Zhao, et al.
Publicado: (2021) -
Quantifying the effects of spirulina supplementation on plasma lipid and glucose concentrations, body weight, and blood pressure
por: Huang H, et al.
Publicado: (2018)